These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6064878)

  • 1. Effect of aggregating agents on platelet electrophoretic mobility.
    Hampton JR; Mitchell JR
    Thromb Diath Haemorrh Suppl; 1967; 26():69-70. PubMed ID: 6064878
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on ADP-induced platelet aggregation in normal and diseased groups.
    Yamakido M; Oishi N; Yokoyama M
    Hawaii Med J; 1970; 29(6):446-9. PubMed ID: 5503441
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody.
    Okuma M; Steiner M; Baldini G
    J Lab Clin Med; 1971 May; 77(5):728-42. PubMed ID: 5557659
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of N-(2-diethylaminoethyl)-N-(2-hydroxy-2-phenylethyl)-2,5-dichloroaniline (AN162) on platelet function and blood coagulation.
    Mac Kenzie RD; Blohm TR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):577-87. PubMed ID: 5004226
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleeding tendency associated with "new" abnormality of platelet behaviour.
    Hardisty RM; Hutton RA
    Lancet; 1967 May; 1(7497):983-5. PubMed ID: 4164609
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the platelet electrophoretic mobility and the microcirculation under the influence of different substances (ADP, ATP, noradrenaline). Attempt to correlate the aggregating (and disaggreating) capacity and the zeta potential].
    Larcan A; Stoltz JF; Stoltz M; Peters A
    C R Seances Soc Biol Fil; 1968 Jul; 162(1):204-9. PubMed ID: 4236010
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of adenosine diphosphate and adrenaline on mean platelet shape.
    O'Brien JR
    Nature; 1965 Jul; 207(994):306-7. PubMed ID: 5886232
    [No Abstract]   [Full Text] [Related]  

  • 9. ADP- and collagen-induced platelet aggregation in vivo and in vitro.
    Zucker MB
    Thromb Diath Haemorrh Suppl; 1967; 26():175-84. PubMed ID: 4863690
    [No Abstract]   [Full Text] [Related]  

  • 10. The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction.
    O'Brien JR; Heywood JB; Heady JA
    Thromb Diath Haemorrh; 1966 Dec; 16(3):752-67. PubMed ID: 5998919
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pyrimido-pyrimidine compounds on platelet function.
    Cucuianu MP; Nishizawa EE; Mustard JF
    J Lab Clin Med; 1971 Jun; 77(6):958-74. PubMed ID: 5559863
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phentolamine, an alpha receptor blocking agent, on epinephrine, ADP and collagen induced factor 4 release and platelet aggregation.
    Kubisz P; Levy-Toledano S; Cronberg S; Pinkhas J; Caen J
    Rev Eur Etud Clin Biol; 1970 Apr; 15(4):429-32. PubMed ID: 4393725
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline.
    Solum NO; Stormorken H
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:170+. PubMed ID: 5862557
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of aggregating agents on electrophoretic mobility of blood platelets from health individuals and from patients with cardiovascular diseases.
    Gröttum KA
    Lancet; 1968 Jun; 1(7557):1406-8. PubMed ID: 4172993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic changes of adenosine diphosphate, adenosine triphosphate, and thrombin in relation to their platelet-aggregating activity.
    Swedenborg J; Taylor G; Olsson P
    Scand J Clin Lab Invest; 1971 May; 27(3):213-9. PubMed ID: 5581182
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin.
    Olas B; Wachowicz B; Szewczuk J; Saluk-Juszczak J; Kaca W
    Microbios; 2001; 105(410):7-13. PubMed ID: 11368092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-platelet interaction: relationship to hemostasis and thrombosis.
    Rodman NF; Mason RG
    Fed Proc; 1967; 26(1):95-105. PubMed ID: 6018930
    [No Abstract]   [Full Text] [Related]  

  • 19. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood cell aggregation and biological agents.
    Swank RL; Fellman JH
    Bibl Anat; 1967; 9():98-103. PubMed ID: 6029913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.